Chronic Inflammation: Root Causes, Disease Drivers, and How to Reverse It

Chronic inflammation is not simply a symptom to be managed. It is the shared biological driver behind cardiovascular disease, autoimmunity, neurodegeneration, cancer, and metabolic dysfunction. Understanding what initiates it, what sustains it, and why the body fails to resolve it is the foundation of effective long-term prevention and recovery.

• Oxidative stress, leaky gut, toxicant burden, and sustained stress responses are the four primary initiators of chronic inflammation.
• Inflammation has two phases. The resolution phase, not just the initiation phase, determines whether the process becomes chronic.
• Glutathione depletion, omega-3 deficiency, adverse childhood events, and dietary triggers all sustain inflammation through documented biological mechanisms.
• Mast cell activation, lymphatic dysfunction, and neuroinflammation represent less commonly recognised but clinically significant pathways.
• Evidence-based protocols for reversal include dietary elimination, specific supplementation, toxicant clearance, trauma release, and laboratory-guided monitoring.

What chronic inflammation actually is

Most people think of inflammation as redness, swelling, or pain. Acute inflammation is exactly that: a short-term, localised repair response the body is designed to complete. Chronic inflammation is different in kind, not just in duration. It is a sustained state in which the immune system's alarm has been triggered but the resolution phase has failed to occur. The immune response stays active indefinitely, continuously consuming resources and generating signalling molecules that damage surrounding tissue over time.

One framework for understanding this is the concept of metaflammation, a state of chronic metabolic inflammation that operates across multiple body systems simultaneously. Rather than expressing as a single named condition, it manifests as a cluster of conditions including hormonal dysfunction, gut disease, cardiovascular disease, blood sugar dysregulation, and neurological decline that share the same underlying driver. Treating each condition as a separate named problem misses the biochemistry generating all of them at once.

The chemistry behind it: oxidative stress and the redox balance

At the cellular level, inflammation begins with oxidative stress. Every cell runs on electron transfer. Reducing agents, including antioxidants and nutrients from food, donate electrons. Oxidising agents, including free radicals and environmental toxicants, accept them. When oxidising agents outnumber reducing agents, the body cannot generate energy efficiently, cellular processes falter, and the conditions for chronic disease emerge.

Four categories of input determine whether the body tips into oxidative stress: diet (the source of all reducing agents), emotional state (sustained stress responses dramatically increase energy demand), environmental exposure (synthetic chemical load, air quality, and water contamination), and existing physiological dysfunction (particularly hormonal imbalance, which disrupts the cellular supervisory signals that coordinate repair). Addressing chronic inflammation means identifying which of these inputs is applying the greatest load and reducing it.

The two phases of inflammation and why resolution fails

The initiation phase of inflammation is well understood. An injury occurs or a threat is detected, immune cells flood the site, and repair begins. The resolution phase is where chronic inflammation diverges from acute. In healthy acute inflammation, the repair crew stands down once the work is done. In chronic inflammation, the resolution never completes. The immune response activates but never de-activates, and each new stressor adds more immune activity on top of an already unresolved process.

The clinical question this raises is not how to suppress inflammation but why resolution is failing. Two factors commonly block it: something the body needs for resolution is absent (adequate glutathione, omega-3 fatty acids, or parasympathetic nervous system activity, for example), or something is continuously re-triggering the initiation phase (dietary antigens crossing a leaky gut wall, retained environmental toxicants, or unresolved neuropeptide signalling from past trauma).

Leaky gut as the central amplifier

Intestinal permeability, the condition in which the tight junctions between gut wall cells open and allow partially digested food proteins and bacterial toxins to pass into the bloodstream, is one of the most consistently documented drivers of systemic chronic inflammation. Research by Professor Alessio Fasano at Harvard Medical School identified zonulin, a protein produced by the gut lining, as the molecular mechanism that controls these tight junctions. When zonulin is triggered, the junctions open, and the resulting cascade of immune activation affects not only the gut but the pancreas, brain, kidneys, and fatigue pathways.

The two inputs most reliably documented to trigger zonulin release are lipopolysaccharide (the toxic component released when certain gut bacteria die or are disrupted) and gluten. Both are present in the standard modern diet. Gluten is particularly significant because it does not only trigger zonulin directly. It also increases gut permeability in a way that amplifies immune reactivity to every other potential antigen. Removing gluten is therefore not simply removing one trigger. It reduces the overall permeability that makes all other triggers more damaging.

Glutathione: the body's master anti-inflammatory molecule

Glutathione is a tripeptide the body manufactures from three amino acids. When glutathione levels are adequate, immune cells called macrophages can clear cellular debris and inhaled particles without generating a broader inflammatory response. When glutathione is depleted, macrophage function is impaired, the immune system calls in more aggressive neutrophils that resolve threats by releasing free radicals into surrounding tissue, and the resulting tissue damage generates further inflammation. The cycle is self-perpetuating.

Glutathione depletion has been documented across a range of chronic conditions including inflammatory bowel disease, autism spectrum disorder, respiratory disease, and COVID-19. In respiratory conditions, the severity of illness tracks directly with the depth of glutathione depletion. Viruses appear to deplete glutathione actively as a mechanism to create a more permissive environment for their own replication. Restoring glutathione through liposomal supplementation supports macrophage clearance and allows the inflammatory load the body was unable to resolve to begin resolving.

Less recognised drivers: mast cell activation and lymphatic dysfunction

Mast cell activation syndrome (MCAS) is a condition in which mast cells, the immune system's first responders to perceived threats, degranulate excessively and unpredictably, releasing histamine, prostaglandins, leukotrienes, and other inflammatory compounds throughout the body. Triggers include synthetic fragrances, preservatives, certain foods, temperature changes, and emotional stress. Symptoms are broad and frequently misdiagnosed: skin reactions, gastrointestinal distress, cardiovascular instability, neurological effects including brain fog and anxiety, and in severe cases anaphylaxis. Conventional allergy medications (antihistamines and leukotriene inhibitors) manage symptom severity but do not address the underlying mast cell reactivity.

The lymphatic system is the body's drainage and immune transport network. Unlike the cardiovascular system, it has no pump. It moves fluid through a combination of physical movement, breathing, and muscular contraction. When lymphatic drainage is insufficient, cellular waste accumulates in the interstitial space around tissues. That accumulated waste generates a local inflammatory environment. Conditions linked to lymphatic insufficiency include chronic fatigue, fibromyalgia, recurrent infection, and oedema. Targeted lymphatic drainage therapy, combined with movement and hydration, addresses the congestion rather than the downstream symptoms.

Childhood trauma, the nervous system, and stored inflammation

The Adverse Childhood Events (ACE) study, conducted by Kaiser Permanente in the 1990s across thousands of participants, found a direct dose-response relationship between the number of adverse childhood events a person experienced and their risk for virtually every chronic disease studied in adulthood. Three or more adverse events were associated with a lifespan reduction of up to 20 years.

The physiological mechanism is neuropeptide storage. When a traumatic event occurs, the brain releases neuropeptides that are stored in body tissue, not only in memory. The inflammatory signalling initiated at the time of trauma does not fully resolve because the tissue retains the biochemical marker of the event. This stored neuropeptide load generates low-level chronic inflammation that can persist for decades. Trauma release practices with documented evidence bases include EMDR (Eye Movement Desensitisation and Reprocessing), RTT (Rapid Transformational Therapy), hypnotherapy, and structured forgiveness meditation. Clinical observation across these modalities consistently shows that resolving stored trauma reduces systemic inflammatory reactivity across multiple systems simultaneously.

What the evidence shows on dietary triggers

Food sensitivity testing across large clinical populations consistently identifies the same seven food categories as the most common dietary drivers of inflammation: gluten, dairy, eggs, soy, corn, peanuts, and sugar combined with artificial sweeteners. A two-week complete elimination of all seven simultaneously removes virtually all processed food from the diet, since processed foods almost universally contain at least one of these ingredients. Most people completing a strict two-week elimination report measurable outcomes: reduced headache frequency, improved energy, reduction in abdominal bloating, and weight loss of approximately 5 pounds despite no reduction in food volume.

Sugar deserves specific attention as both a toxin and a neurological trap. A single sugary drink or snack suppresses immune system activity for several hours after consumption. In patterns of continuous daily intake, the cumulative effect is near-constant immune suppression. Sugar also feeds Candida, a gut yeast organism that at elevated populations releases aldehydes producing brain fog and fatigue, and releases chemical signals that generate intense sugar cravings. The cravings are a biochemical signal from an organism using the host's neurological reward system for its own food supply. They are not a matter of willpower.

Measuring and monitoring inflammation

Laboratory assessment of chronic inflammation works in tiers. Standard non-specific markers include erythrocyte sedimentation rate (ESR), which measures how quickly red blood cells settle as a proxy for inflammatory protein levels, and C-reactive protein (CRP), produced by the liver in response to systemic inflammation and associated with cardiovascular risk at low elevations. Deeper assessment uses cytokine profiling. Tumour necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are pro-inflammatory signalling molecules that are typically elevated in active chronic inflammatory states. Interleukin-10 (IL-10) is an anti-inflammatory cytokine that is typically low when chronic inflammation is unresolved.

The ratio of omega-3 to omega-6 fatty acids in the body is one of the most clinically informative nutritional inflammation markers available. Omega-3 fatty acids are broadly anti-inflammatory across brain, skin, and cardiovascular tissue. Omega-6 fatty acids are pro-inflammatory. The optimal physiological ratio is approximately 1:1, achievable with significant fatty fish consumption and minimal processed food. In patients on standard Western diets dominated by seed oils and grain-fed animal products, measured ratios of 1:15 and higher are common. That represents fifteen times the pro-inflammatory fatty acid load the body is designed to carry, purely from nutritional imbalance, and it is correctable through supplementation and dietary adjustment.

Where these ideas come from

The ideas in this section of the knowledge base originate from the work of Zonia, specifically the Taming Inflammation docuseries, published through the Zonia platform in 2021. The series features 18 practitioners and researchers including integrative physicians, functional medicine clinicians, naturopathic oncologists, pharmacists, and specialists in glutathione research, neuroinflammation, environmental medicine, and trauma. Contributors include James LaValle RPh MS CCN, Dr Afrouz Demeri, Dr Tim Guilford, Dr Tom O'Bryan, Dr Gina Nick, JJ Virgin, Nathan Crane, Dr Deb Matthew, Dr Jake Psenka, and others. If you want to experience the original work in full, it is available directly through the Zonia platform.

The knowledge base itself is an independent work. Every concept has been studied, rewritten from scratch, and restructured for use in a multi-source advisory system. Nothing from the original has been reproduced. The knowledge has been transformed, not copied. The source is named clearly because the ideas deserve proper credit, and because the original work stands on its own merits.